- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
top
This section of AVAC Report 2013 describes the range of issues that have been raised by recent data of microbicide and PrEP trials in women, particularly data from some trials that showed few women used the products as prescribed. It presents analysis on what low adherence data do and do not tell the field about what women want and will use—and makes recommendations for next steps.